Tale of Compounding Oddities

Overview

Journal BMJ Case Rep

Specialty General Medicine

Date 2021 Mar 5

PMID 33664024

Authors

Umang Agrawal

Krutarth Kanjiya

Camilla Rodrigues

Ayesha Sunavala

Affiliations

Soon will be listed here.

Abstract

We present a case of a 59-year-old man, who on being evaluated for abdominal pain and headache, was found to have a pancreatic head mass and inflammatory hypophysitis. Xpert MTB/Rif of the pancreatic mass biopsy showed the presence of tuberculosis (TB) with a very low load, and rifampicin resistance was detected with absence of probes A and B. Pyrosequencing (a novel genotypic test for TB) of the Xpert MTB/Rif isolate detected a single, rare, high-confidence mutation (S512T) in the rpoB region (rifampicin resistance determining region in the MTB genome). The TB mycobacteria growth indicator tube (TBMGIT) phenotypic drug susceptibility test (DST), however, showed rifampicin susceptibility. Incidentally, he was unable to tolerate rifampicin and responded well to a non-rifampicin-based regimen. We discuss a possible hypothesis of the Xpert-DST discordance in accordance with a recent literature review on phenotypic DST methods. We also discuss the utility of pyrosequencing in clinical practice for the diagnosis of TB and its resistance patterns.

References

Georghiou S, Seifert M, Catanzaro D, Garfein R, Valafar F, Crudu V . Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape. Antimicrob Agents Chemother. 2016; 60(7):3994-4004. PMC: 4914621. DOI: 10.1128/AAC.00222-16. View

Wu C, Wang S, Kuo T . Pancreatic tuberculosis mimicking pancreatic head carcinoma: a case report and review of the literature. Infection. 1994; 22(4):287-9. DOI: 10.1007/BF01739920. View

Bum Cho S . Pancreatic tuberculosis presenting with pancreatic cystic tumor: a case report and review of the literature. Korean J Gastroenterol. 2009; 53(5):324-8. DOI: 10.4166/kjg.2009.53.5.324. View

Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T . Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012; 22(1):21-30. DOI: 10.1007/s10165-011-0571-z. View

Ajbani K, Lin S, Rodrigues C, Nguyen D, Arroyo F, Kaping J . Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries. Antimicrob Agents Chemother. 2014; 59(1):414-20. PMC: 4291380. DOI: 10.1128/AAC.03614-14. View

Van Deun A, Aung K, Bola V, Lebeke R, Hossain M, De Rijk W . Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol. 2013; 51(8):2633-40. PMC: 3719626. DOI: 10.1128/JCM.00553-13. View

Miotto P, Cabibbe A, Borroni E, Degano M, Cirillo D . Role of Disputed Mutations in the Gene in Interpretation of Automated Liquid MGIT Culture Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosis. J Clin Microbiol. 2018; 56(5). PMC: 5925711. DOI: 10.1128/JCM.01599-17. View

Torrea G, Ng K, Van Deun A, Andre E, Kaisergruber J, Ssengooba W . Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance. Sci Rep. 2019; 9(1):11826. PMC: 6694172. DOI: 10.1038/s41598-019-48401-z. View

Rufai S, Kumar P, Singh A, Prajapati S, Balooni V, Singh S . Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis. J Clin Microbiol. 2014; 52(6):1846-52. PMC: 4042801. DOI: 10.1128/JCM.03005-13. View

10.

Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks A, Emerson C . A standardised method for interpreting the association between mutations and phenotypic drug resistance in . Eur Respir J. 2017; 50(6). PMC: 5898944. DOI: 10.1183/13993003.01354-2017. View

11.

Bhardwaj M, Sharma A, Pal H . Granulomatous hypophysitis. Neurol India. 2005; 53(3):364-5. DOI: 10.4103/0028-3886.16949. View

12.

Ocheretina O, Byrt E, Mabou M, Royal-Mardi G, Merveille Y, Rouzier V . False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load. Diagn Microbiol Infect Dis. 2016; 85(1):53-5. PMC: 4841693. DOI: 10.1016/j.diagmicrobio.2016.01.009. View

13.

DCruz S, Sachdev A, Kaur L, Handa U, Bhalla A, Lehl S . Fine needle aspiration diagnosis of isolated pancreatic tuberculosis. A case report and review of literature. JOP. 2003; 4(4):158-62. View

14.

Sahrin M, Rahman A, Uddin M, Kabir S, Kabir S, Houpt E . Discordance in Xpert MTB/RIF assay results among low bacterial load clinical specimens in Bangladesh. Int J Tuberc Lung Dis. 2018; 22(9):1056-1062. DOI: 10.5588/ijtld.17.0792. View

15.

Chari S, Takahashi N, Levy M, Smyrk T, Clain J, Pearson R . A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009; 7(10):1097-103. DOI: 10.1016/j.cgh.2009.04.020. View

16.

Wallace Z, Naden R, Chari S, Choi H, Della-Torre E, Dicaire J . The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2019; 79(1):77-87. DOI: 10.1136/annrheumdis-2019-216561. View

17.

Ahmed S, Shukla I, Fatima N, Varshney S, Shameem M, Tayyaba U . Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India. Int J Mycobacteriol. 2018; 7(4):315-327. DOI: 10.4103/ijmy.ijmy_98_18. View